Skip to main content

Peer Review reports

From: Budget impact model of Mydrane®, a new intracameral injectable used for intra-operative mydriasis, from a UK hospital perspective

Original Submission
22 Dec 2016 Submitted Original manuscript
9 Jan 2017 Reviewed Reviewer Report - Bingqian Liu
19 Jan 2017 Reviewed Reviewer Report - martha kim
17 Feb 2017 Author responded Author comments - Keith Davey
Resubmission - Version 2
17 Feb 2017 Submitted Manuscript version 2
21 Feb 2017 Reviewed Reviewer Report - martha kim
26 Feb 2017 Reviewed Reviewer Report - Bingqian Liu
28 Apr 2017 Author responded Author comments - Keith Davey
Resubmission - Version 3
28 Apr 2017 Submitted Manuscript version 3
7 Jul 2017 Author responded Author comments - Keith Davey
Resubmission - Version 4
7 Jul 2017 Submitted Manuscript version 4
1 Mar 2018 Author responded Author comments - Keith Davey
Resubmission - Version 5
1 Mar 2018 Submitted Manuscript version 5
Publishing
16 Mar 2018 Editorially accepted
19 Apr 2018 Article published 10.1186/s12886-018-0746-x

You can find further information about peer review here.

Back to article page